Tenders/Cytostatic for CAR-T therapy - ciltacabtagen autoleucel
Awarded🇨🇿Czech RepublicSupplies

Cytostatic for CAR-T therapy - ciltacabtagen autoleucel

Auto-translated from cs
Original title: cytostatikum pro CAR-T terapii - ciltakabtagen autoleucel
Fakultní nemocnice Plzeň
Published: Sep 16, 2026
Updated: Sep 19, 2026
Source: TED - Tenders Electronic Daily (EU)

This tender has been awarded

Awarded to Janssen-Cilag s.r.o. — CZK 297,935,906

Browse open Health & Medical tenders in Czech Republic

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Czech Republic, Europe, this opportunity is open to firms and consortiums, with an estimated budget of CZK 297.9 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from cs
Cytostatic for CAR-T therapy (ciltacabtagen autoleucel) - infusion bag containing cell dispersion of 3.2x10⁶ to 1x10⁸ viable anti-BCMA CAR-positive T-lymphocytes. The estimated annual volume is 10 infusion bags containing an individually determined amount of the active ingredient, ATC L01XL05. A dose is understood as an infusion bag for single administration containing the specified active ingredient in an amount determined individually according to the needs of the specific patient. The offered medicinal product must meet the requirements of SÚKL. SÚKL registration is a necessary condition for the standard use of medicinal products within the provision of healthcare according to § 8 para. 1 of Act No. 378/2007 Coll., on medicinal products. The participant proves compliance with this condition by stating the valid SÚKL code of the offered medicinal product in the relevant column of the table for completing offer prices, which is part of Annex No. 1 to the tender documentation (see point 9.2.). The medicinal product is intended for the treatment of adult patients with relapsed and refractory multiple myeloma who have undergone at least one previous therapy including an immunomodulator and a proteasome inhibitor and who have shown disease progression during the last treatment and are refractory to lenalidomide. Considering that the production of medicinal products for autologous immunocellular therapy involves highly demanding and specific procedures and is conditional on the collection of biological material from patients, the contracting authority allows for the conclusion of a separate contract/separate contracts, governing the detailed conditions of cooperation and defining the responsibility of individual professional workplaces in different phases of the production and therapeutic process (collection and processing of biological material, conditions for handling the product, ensuring product quality, process documentation, qualification and certification, etc.). However, the content of any of these contracts must not conflict with the conditions of this tender documentation, including the conditions of the purchase contract.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 16, 2026. Last refreshed 60 days ago. Original language: cs. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About Fakultní nemocnice Plzeň

Fakultní nemocnice Plzeň has issued 112 procurement notices on BidsFactory, including 9 currently open and 51 awarded contracts. Activity concentrates in Health & Medical, Information & Communication Technology, and General Supplies & Services. All notices are published for Czech Republic. Notices are distributed via TED - Tenders Electronic Daily (EU). Most recent publication: November 16, 2026.

Fakultní nemocnice Plzeň: buyer profile, tenders and awards

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in Czech Republic. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to Janssen-Cilag s.r.o.. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by Fakultní nemocnice Plzeň in Czech Republic. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

Janssen-Cilag s.r.o. was awarded the contract for CZK 297,935,906. The figure reflects the value disclosed by the contracting authority in the award notice.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Estimated Budget
CZK 297,935,907
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
cs

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

Fakultní nemocnice Plzeň
🇨🇿Czech Republic

Contact